WallStreetZenWallStreetZen

NASDAQ: RXST
Rxsight Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RXST

Based on 4 analysts offering 12 month price targets for Rxsight Inc.
Min Forecast
$17.00-34.69%
Avg Forecast
$21.75-16.44%
Max Forecast
$27.00+3.73%

Should I buy or sell RXST stock?

Based on 4 analysts offering ratings for Rxsight Inc.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RXST stock forecasts and price targets.

RXST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Needham
Top 27%
74
BuyMaintains$27.00+3.73%2023-05-10
Wells Fargo
Top 8%
93
HoldMaintains$17.00-34.69%2023-05-10
Oppenheimer
Bottom 6%
6
BuyInitiates Coverage On$23.00-11.64%2023-04-13
JP Morgan
Top 17%
84
Strong BuyMaintains$20.00-23.17%2023-03-07

1 of 1

Forecast return on equity

Is RXST forecast to generate an efficient return?
Company
-52.49%
Industry
23.68%
Market
89.83%
RXST's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RXST forecast to generate an efficient return on assets?
Company
-37.58%
Industry
12.6%
RXST is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RXST revenue growth forecast

How is RXST forecast to perform vs Medical Devices companies and vs the US market?
Company
28.91%
Industry
7.08%
Market
8.87%
RXST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RXST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RXST vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RXST$26.03$21.75-16.44%Buy
VREX$22.29$24.00+7.67%Hold
SIBN$26.36$27.57+4.59%Strong Buy
QTRX$20.36$27.00+32.61%Strong Buy
NVRO$28.27$43.25+52.99%Hold
View Top Medical Device Stocks

Rxsight Stock Forecast FAQ

Is Rxsight Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RXST) stock is to Buy RXST stock.

Out of 4 analysts, 1 (25%) are recommending RXST as a Strong Buy, 2 (50%) are recommending RXST as a Buy, 1 (25%) are recommending RXST as a Hold, 0 (0%) are recommending RXST as a Sell, and 0 (0%) are recommending RXST as a Strong Sell.

If you're new to stock investing, here's how to buy Rxsight stock.

What is RXST's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: RXST) forecast ROE is -52.49%, which is considered weak.

What is RXST's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RXST price target, the average RXST price target is $21.75, with the highest RXST stock price forecast at $27.00 and the lowest RXST stock price forecast at $17.00.

On average, Wall Street analysts predict that Rxsight's share price could fall to $21.75 by May 10, 2024. The average Rxsight stock price prediction forecasts a potential downside of 16.44% from the current RXST share price of $26.03.

What is RXST's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: RXST) forecast ROA is -37.58%, which is lower than the forecast US Medical Devices industry average of 12.6%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.